Matthew B. Stanbrook, MD, PhD
Cardiology:
Pulmonology:
Stanbrook MB. Review: Inhaled anticholinergics increase risk for major cardiovascular events in chronic obstructive pulmonary disease. Ann Intern Med. 2009;150:JC1–6. doi: https://doi.org/10.7326/0003-4819-150-2-200901200-02006
Download citation file:
© 2019
Published: Ann Intern Med. 2009;150(2):JC1-6.
DOI: 10.7326/0003-4819-150-2-200901200-02006
Chronic Obstructive Airway Disease, Pulmonary/Critical Care.
Results provided by: